$HZNP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Horizon Therapeutics Public Ltd Co.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Horizon Therapeutics Public Ltd Co. Get notifications about new insider transactions in Horizon Therapeutics Public Ltd Co for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 12 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Sep 20 2016 | HZNP | Horizon Pharma plc | Daniel William F | Director | Buy | M | 0.00 | 7,874 | 0 | 17,035 | 9.2 K to 17 K (+85.95 %) |
Sep 13 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Option Exercise | M | 0.00 | 3,925 | 0 | 7,850 | |
Sep 13 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Payment of Exercise | F | 18.89 | 1,644 | 31,055 | 43,612 | 45.3 K to 43.6 K (-3.63 %) |
Sep 13 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Buy | M | 0.00 | 3,925 | 0 | 45,256 | 41.3 K to 45.3 K (+9.50 %) |
Aug 19 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 2.40 | 8,330 | 19,992 | 138,670 | |
Aug 19 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 2.40 | 8,330 | 19,992 | 334,874 | 326.5 K to 334.9 K (+2.55 %) |
Aug 08 2016 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Option Exercise | M | 0.00 | 18,750 | 0 | 56,250 | |
Aug 08 2016 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Payment of Exercise | F | 20.10 | 5,129 | 103,093 | 21,335 | 26.5 K to 21.3 K (-19.38 %) |
Aug 08 2016 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Buy | M | 0.00 | 18,750 | 0 | 26,464 | 7.7 K to 26.5 K (+243.06 %) |
Aug 02 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 20.00 | 2,900 | 58,000 | 159,250 | 162.2 K to 159.3 K (-1.79 %) |
Jun 27 2016 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 20,000 | 0 | 40,000 | |
Jun 27 2016 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 17.44 | 8,643 | 150,734 | 46,529 | 55.2 K to 46.5 K (-15.67 %) |
Jun 27 2016 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 20,000 | 0 | 55,172 | 35.2 K to 55.2 K (+56.86 %) |
Jun 15 2016 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Sell | S | 17.69 | 25,000 | 442,280 | 189,836 | 214.8 K to 189.8 K (-11.64 %) |
May 20 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Option Exercise | M | 0.00 | 16,075 | 0 | 32,150 | |
May 20 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Payment of Exercise | F | 14.61 | 5,000 | 73,050 | 39,281 | 44.3 K to 39.3 K (-11.29 %) |
May 20 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Buy | M | 0.00 | 16,075 | 0 | 44,281 | 28.2 K to 44.3 K (+56.99 %) |
May 10 2016 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | M | 0.00 | 5,258 | 0 | 0 | |
May 10 2016 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Payment of Exercise | F | 13.41 | 1,418 | 19,015 | 3,840 | 5.3 K to 3.8 K (-26.97 %) |
May 10 2016 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Buy | M | 0.00 | 5,258 | 0 | 5,258 | 0 to 5.3 K |
May 10 2016 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | M | 0.00 | 5,258 | 0 | 0 | |
May 10 2016 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Payment of Exercise | F | 13.41 | 1,418 | 19,015 | 3,840 | 5.3 K to 3.8 K (-26.97 %) |
May 10 2016 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Buy | M | 0.00 | 5,258 | 0 | 5,258 | 0 to 5.3 K |
May 10 2016 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | M | 0.00 | 5,258 | 0 | 0 | |
May 10 2016 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Buy | M | 0.00 | 5,258 | 0 | 5,258 | 0 to 5.3 K |
May 10 2016 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | M | 0.00 | 5,258 | 0 | 0 | |
May 10 2016 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Buy | M | 0.00 | 5,258 | 0 | 5,258 | 0 to 5.3 K |
May 10 2016 | HZNP | Horizon Pharma plc | Thomas John B | EVP, Corporate Stra ... | Option Exercise | M | 0.00 | 9,375 | 0 | 28,125 | |
May 10 2016 | HZNP | Horizon Pharma plc | Thomas John B | EVP, Corporate Stra ... | Payment of Exercise | F | 13.41 | 2,916 | 39,104 | 7,620 | 10.5 K to 7.6 K (-27.68 %) |
May 10 2016 | HZNP | Horizon Pharma plc | Thomas John B | EVP, Corporate Stra ... | Buy | M | 0.00 | 9,375 | 0 | 10,536 | 1.2 K to 10.5 K (+807.49 %) |
May 10 2016 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | M | 0.00 | 5,258 | 0 | 0 | |
May 10 2016 | HZNP | Horizon Pharma plc | Daniel William F | Director | Payment of Exercise | F | 13.41 | 1,590 | 21,322 | 9,161 | 10.8 K to 9.2 K (-14.79 %) |
May 10 2016 | HZNP | Horizon Pharma plc | Daniel William F | Director | Buy | M | 0.00 | 5,258 | 0 | 10,751 | 5.5 K to 10.8 K (+95.72 %) |
May 10 2016 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | M | 0.00 | 5,258 | 0 | 0 | |
May 10 2016 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Buy | M | 0.00 | 5,258 | 0 | 5,258 | 0 to 5.3 K |
May 05 2016 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
May 05 2016 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
May 05 2016 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
May 05 2016 | HZNP | Horizon Pharma plc | SANTINI GINO | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
May 05 2016 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
May 05 2016 | HZNP | Horizon Pharma plc | Pauli Ronald | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
May 05 2016 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
May 05 2016 | HZNP | Horizon Pharma plc | Nohria Virinder | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
May 05 2016 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
May 05 2016 | HZNP | Horizon Pharma plc | Himawan Jeff | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
May 05 2016 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
May 05 2016 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
May 05 2016 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 0.00 | 13,953 | 0 | 13,953 | |
May 05 2016 | HZNP | Horizon Pharma plc | GREY MICHAEL G | Director | Option Exercise | A | 15.23 | 23,092 | 351,691 | 23,092 | |
Apr 04 2016 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Option Exercise | M | 0.00 | 7,000 | 0 | 21,000 | |
Apr 04 2016 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Payment of Exercise | F | 17.37 | 1,915 | 33,264 | 6,177 | 8.1 K to 6.2 K (-23.67 %) |
Apr 04 2016 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Buy | M | 0.00 | 7,000 | 0 | 8,092 | 1.1 K to 8.1 K (+641.03 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 9,500 | 0 | 28,500 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 16.32 | 2,955 | 48,226 | 16,468 | 19.4 K to 16.5 K (-15.21 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 9,500 | 0 | 19,423 | 9.9 K to 19.4 K (+95.74 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 0.00 | 9,500 | 0 | 28,500 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Payment of Exercise | F | 16.32 | 2,955 | 48,226 | 17,681 | 20.6 K to 17.7 K (-14.32 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Buy | M | 0.00 | 9,500 | 0 | 20,636 | 11.1 K to 20.6 K (+85.31 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 19,250 | 0 | 57,750 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 16.32 | 8,798 | 143,583 | 160,100 | 168.9 K to 160.1 K (-5.21 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 19,250 | 0 | 168,898 | 149.6 K to 168.9 K (+12.86 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | Kelly David George | EVP, Company Secret ... | Option Exercise | M | 0.00 | 19,250 | 0 | 57,750 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | Kelly David George | EVP, Company Secret ... | Buy | M | 0.00 | 19,250 | 0 | 19,250 | 0 to 19.3 K |
Mar 24 2016 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 9,500 | 0 | 28,500 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 16.32 | 2,955 | 48,226 | 37,081 | 40 K to 37.1 K (-7.38 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 9,500 | 0 | 40,036 | 30.5 K to 40 K (+31.11 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Option Exercise | M | 0.00 | 19,250 | 0 | 57,750 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Payment of Exercise | F | 16.32 | 5,987 | 97,708 | 28,206 | 34.2 K to 28.2 K (-17.51 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, COO | Buy | M | 0.00 | 19,250 | 0 | 34,193 | 14.9 K to 34.2 K (+128.82 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 31,000 | 0 | 93,000 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 16.32 | 9,641 | 157,341 | 33,721 | 43.4 K to 33.7 K (-22.23 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 31,000 | 0 | 43,362 | 12.4 K to 43.4 K (+250.77 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,000 | 0 | 93,000 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 16.32 | 14,167 | 231,205 | 38,242 | 52.4 K to 38.2 K (-27.03 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,000 | 0 | 52,409 | 21.4 K to 52.4 K (+144.80 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 125,000 | 0 | 375,000 | |
Mar 24 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 16.32 | 57,125 | 932,280 | 324,493 | 381.6 K to 324.5 K (-14.97 %) |
Mar 24 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 125,000 | 0 | 381,618 | 256.6 K to 381.6 K (+48.71 %) |
Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Option Exercise | M | 0.00 | 31,025 | 0 | 62,050 | |
Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Payment of Exercise | F | 16.78 | 9,616 | 161,356 | 21,409 | 31 K to 21.4 K (-30.99 %) |
Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Buy | M | 0.00 | 31,025 | 0 | 31,025 | 0 to 31 K |
Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Gift | G | 0.00 | 24,406 | 0 | 82,061 | 57.7 K to 82.1 K (+42.33 %) |
Mar 07 2016 | HZNP | Horizon Pharma plc | Carey Robert | EVP, Chief Business ... | Gift | G | 0.00 | 24,406 | 0 | 0 | 24.4 K to 0 (-100.00 %) |
Feb 29 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 20.00 | 4,100 | 82,000 | 149,648 | 153.7 K to 149.6 K (-2.67 %) |
Apr 19 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 2.40 | 7,860 | 18,864 | 1,815 | |
Apr 19 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Option Exercise | M | 7.48 | 2,140 | 16,007 | 7,860 | |
Apr 19 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Buy | M | 2.40 | 7,860 | 18,864 | 27,681 | 19.8 K to 27.7 K (+39.65 %) |
Apr 19 2016 | HZNP | Horizon Pharma plc | ACKERMAN TIMOTHY J. | SVP, Commercial Ope ... | Buy | M | 7.48 | 2,140 | 16,007 | 19,821 | 17.7 K to 19.8 K (+12.10 %) |
Apr 11 2016 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | SVP, Corporate Comm ... | Option Exercise | M | 0.00 | 7,000 | 0 | 21,000 | |
Apr 11 2016 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | SVP, Corporate Comm ... | Payment of Exercise | F | 18.80 | 2,177 | 40,928 | 5,081 | 7.3 K to 5.1 K (-29.99 %) |
Apr 11 2016 | HZNP | Horizon Pharma plc | CURTIS GEOFFREY M. | SVP, Corporate Comm ... | Buy | M | 0.00 | 7,000 | 0 | 7,258 | 258 to 7.3 K (+2,713.18 %) |
Jan 05 2016 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 3,200 | 0 | 6,400 | |
Jan 05 2016 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | M | 0.00 | 8,000 | 0 | 8,000 | |
Jan 05 2016 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Payment of Exercise | F | 21.67 | 3,741 | 81,067 | 26,402 | 30.1 K to 26.4 K (-12.41 %) |
Jan 05 2016 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Buy | M | 0.00 | 11,200 | 0 | 30,143 | 18.9 K to 30.1 K (+59.12 %) |
Jan 05 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 15,500 | 0 | 31,000 | |
Jan 05 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 11,250 | 0 | 11,250 | |
Jan 05 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 21.67 | 8,576 | 185,842 | 153,748 | 162.3 K to 153.7 K (-5.28 %) |
Jan 05 2016 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 26,750 | 0 | 162,324 | 135.6 K to 162.3 K (+19.73 %) |
Jan 05 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 49,500 | 0 | 99,000 | |
Jan 05 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 32,175 | 0 | 32,175 | |
Jan 05 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 21.67 | 30,845 | 668,411 | 256,618 | 287.5 K to 256.6 K (-10.73 %) |
Jan 05 2016 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 81,675 | 0 | 287,463 | 205.8 K to 287.5 K (+39.69 %) |
Dec 16 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 4.96 | 17,692 | 87,752 | 33,479 | |
Dec 16 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 2.40 | 12,750 | 30,600 | 13,813 | |
Dec 16 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 4.96 | 17,692 | 87,752 | 135,574 | 117.9 K to 135.6 K (+15.01 %) |
Dec 16 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 2.40 | 12,750 | 30,600 | 117,882 | 105.1 K to 117.9 K (+12.13 %) |
Dec 14 2015 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 4.96 | 2,082 | 10,327 | 196,794 | |
Dec 14 2015 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 4.96 | 2,082 | 10,327 | 205,788 | 203.7 K to 205.8 K (+1.02 %) |
Dec 10 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | S | 20.00 | 4,456 | 89,120 | 105,132 | 100.7 K to 105.1 K (+4.43 %) |
Dec 09 2015 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Option Exercise | M | 0.00 | 33,211 | 0 | 0 | |
Dec 09 2015 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Payment of Exercise | F | 21.40 | 15,178 | 324,809 | 203,706 | 218.9 K to 203.7 K (-6.93 %) |
Dec 09 2015 | HZNP | Horizon Pharma plc | Walbert Timothy P | Chairman, President ... | Buy | M | 0.00 | 33,211 | 0 | 218,884 | 185.7 K to 218.9 K (+17.89 %) |
Dec 09 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 0.00 | 8,208 | 0 | 0 | |
Dec 09 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Payment of Exercise | F | 21.40 | 3,752 | 80,293 | 109,588 | 113.3 K to 109.6 K (-3.31 %) |
Dec 09 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 0.00 | 8,208 | 0 | 113,340 | 105.1 K to 113.3 K (+7.81 %) |
Dec 02 2015 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Option Exercise | M | 0.00 | 8,450 | 0 | 25,350 | |
Dec 02 2015 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Payment of Exercise | F | 21.30 | 2,628 | 55,976 | 9,923 | 12.6 K to 9.9 K (-20.94 %) |
Dec 02 2015 | HZNP | Horizon Pharma plc | McHugh Miles W | Sr VP & Princ. Acct ... | Buy | M | 0.00 | 8,450 | 0 | 12,551 | 4.1 K to 12.6 K (+206.05 %) |
Nov 25 2015 | HZNP | Horizon Pharma plc | Kody John J | EVP, Chief Commerci ... | Option Exercise | M | 0.00 | 18,975 | 0 | 56,925 | |
Nov 25 2015 | HZNP | Horizon Pharma plc | Kody John J | EVP, Chief Commerci ... | Payment of Exercise | F | 21.68 | 6,209 | 134,611 | 12,766 | 19 K to 12.8 K (-32.72 %) |
Nov 25 2015 | HZNP | Horizon Pharma plc | Kody John J | EVP, Chief Commerci ... | Buy | M | 0.00 | 18,975 | 0 | 18,975 | 0 to 19 K |
Sep 21 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 31.78 | 7,750 | 246,295 | 105,132 | 112.9 K to 105.1 K (-6.87 %) |
Sep 21 2015 | HZNP | Horizon Pharma plc | Daniel William F | Director | Option Exercise | M | 0.00 | 7,874 | 0 | 15,748 | |
Sep 21 2015 | HZNP | Horizon Pharma plc | Daniel William F | Director | Payment of Exercise | F | 31.92 | 2,381 | 76,002 | 5,493 | 7.9 K to 5.5 K (-30.24 %) |
Sep 21 2015 | HZNP | Horizon Pharma plc | Daniel William F | Director | Buy | M | 0.00 | 7,874 | 0 | 7,874 | 0 to 7.9 K |
Sep 15 2015 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Corporate Deve ... | Option Exercise | M | 0.00 | 3,925 | 0 | 11,775 | |
Sep 15 2015 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Corporate Deve ... | Payment of Exercise | F | 28.99 | 1,794 | 52,008 | 14,180 | 16 K to 14.2 K (-11.23 %) |
Sep 15 2015 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Corporate Deve ... | Buy | M | 0.00 | 3,925 | 0 | 15,974 | 12 K to 16 K (+32.58 %) |
Aug 21 2015 | HZNP | Horizon Pharma plc | Watkins Thomas | Director | Buy | P | 31.32 | 10,000 | 313,240 | 10,000 | 0 to 10 K |
Aug 07 2015 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Option Exercise | A | 0.00 | 800,000 | 0 | 800,000 | |
Aug 07 2015 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Option Exercise | A | 0.00 | 75,000 | 0 | 75,000 | |
Aug 07 2015 | HZNP | Horizon Pharma plc | HAMPTON GEORGE P | See remarks | Option Exercise | A | 35.06 | 200,000 | 7,012,000 | 200,000 | |
Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 4.96 | 2,450 | 12,152 | 51,171 | |
Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Option Exercise | M | 2.40 | 24,437 | 58,649 | 26,563 | |
Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 35.55 | 2,450 | 87,098 | 112,882 | 115.3 K to 112.9 K (-2.12 %) |
Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 4.96 | 2,450 | 12,152 | 115,332 | 112.9 K to 115.3 K (+2.17 %) |
Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Sell | S | 35.55 | 24,437 | 868,735 | 112,882 | 137.3 K to 112.9 K (-17.80 %) |
Jul 17 2015 | HZNP | Horizon Pharma plc | SHERMAN JEFFREY W | EVP and Chief Medic ... | Buy | M | 2.40 | 24,437 | 58,649 | 137,319 | 112.9 K to 137.3 K (+21.65 %) |
Jun 24 2015 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Option Exercise | M | 0.00 | 20,000 | 0 | 60,000 | |
Jun 24 2015 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Payment of Exercise | F | 34.27 | 8,799 | 301,542 | 11,201 | 20 K to 11.2 K (-43.99 %) |
Jun 24 2015 | HZNP | Horizon Pharma plc | Hoelscher Paul W. | EVP, CFO | Buy | M | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
May 21 2015 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Corporate Deve ... | Option Exercise | M | 0.00 | 16,075 | 0 | 48,225 | |
May 21 2015 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Corporate Deve ... | Payment of Exercise | F | 29.22 | 7,270 | 212,429 | 10,761 | 18 K to 10.8 K (-40.32 %) |
May 21 2015 | HZNP | Horizon Pharma plc | MOZE BARRY | EVP, Corporate Deve ... | Buy | M | 0.00 | 16,075 | 0 | 18,031 | 2 K to 18 K (+821.83 %) |
May 08 2015 | HZNP | Horizon Pharma plc | McHugh Miles W | Principal Accountin ... | Option Exercise | A | 0.00 | 99,000 | 0 | 99,000 | |
May 08 2015 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | A | 0.00 | 558,000 | 0 | 558,000 | |
May 08 2015 | HZNP | Horizon Pharma plc | Beeler Brian K | EVP, General Counse ... | Option Exercise | A | 0.00 | 153,000 | 0 | 153,000 | |
May 08 2015 | HZNP | Horizon Pharma plc | Thomas John B | EVP, Corporate Stra ... | Option Exercise | A | 0.00 | 450,000 | 0 | 450,000 | |
May 08 2015 | HZNP | Horizon Pharma plc | Thomas John B | EVP, Corporate Stra ... | Option Exercise | A | 0.00 | 150,000 | 0 | 150,000 |